UK Markets close in 4 hrs 41 mins
  • FTSE 100

    7,141.95
    +12.74 (+0.18%)
     
  • FTSE 250

    22,778.61
    +93.77 (+0.41%)
     
  • AIM

    1,191.19
    +2.45 (+0.21%)
     
  • GBP/EUR

    1.1740
    -0.0026 (-0.22%)
     
  • GBP/USD

    1.3273
    -0.0029 (-0.2203%)
     
  • BTC-GBP

    42,952.44
    +291.89 (+0.68%)
     
  • CMC Crypto 200

    1,457.36
    +18.47 (+1.28%)
     
  • S&P 500

    4,577.10
    +64.06 (+1.42%)
     
  • DOW

    34,639.79
    +617.75 (+1.82%)
     
  • CRUDE OIL

    68.10
    +1.60 (+2.41%)
     
  • GOLD FUTURES

    1,772.30
    +9.60 (+0.54%)
     
  • NIKKEI 225

    28,029.57
    +276.20 (+1.00%)
     
  • HANG SENG

    23,766.69
    -22.24 (-0.09%)
     
  • DAX

    15,264.78
    +1.67 (+0.01%)
     
  • CAC 40

    6,789.72
    -6.03 (-0.09%)
     
Markets:

European stock markets push higher as Omicron strain concerns ease

Global Bioprosthetics Market Research Report (2021 to 2026) - by Type, Application and Region - ResearchAndMarkets.com

·4-min read

DUBLIN, October 18, 2021--(BUSINESS WIRE)--The "Bioprosthetics Market Research Report by Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Bioprosthetics Market size was estimated at USD 3,520.68 million in 2020, is expected to reach USD 4,192.67 million in 2021, and projected to grow at a CAGR of 19.42% reaching USD 10,214.27 million by 2026.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioprosthetics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bioprosthetics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioprosthetics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioprosthetics Market?

4. What is the competitive strategic window for opportunities in the Global Bioprosthetics Market?

5. What are the technology trends and regulatory frameworks in the Global Bioprosthetics Market?

6. What is the market share of the leading vendors in the Global Bioprosthetics Market?

7. What modes and strategic moves are considered suitable for entering the Global Bioprosthetics Market?

Market Dynamics

Drivers

  • Rising prevalence of chronic and cardiovascular diseases resulted in increasing demand for long-term treatment

  • Growing geriatric population characterized with a higher susceptibility to develop degenerative cardiac diseases

  • Use of bioprosthetics to reduce morbidity associated with cardiac valve disorders

Restraints

  • Threat associated with infections

Opportunities

  • Advancement in technology and rapid evolution in tissue-engineered bioprostheses to eventually replace purely synthetic mechanical heart valves

  • Increasing research and development activities are being funded by the government and private companies

  • Compatibility issues with synthetic or mechanical implants

Challenges

  • Issues pertaining to valve durability and compatibility

Companies Mentioned

  • Aortech International PLC

  • Braile Biomedica, Inc.

  • CryoLife, Inc.

  • Edwards Lifesciences Corporation

  • Ethicon, Inc.

  • Hancock Jaffe Laboratories, Inc.

  • Humacyte, Inc.

  • JenaValve Technology GmbH

  • Labcor Laboratorios Ltd.

  • LeMaitre Vascular, Inc.

  • LifeCell International

  • LivaNova, PLC

  • Maquet Metinge Group

  • Medtronic PLC

  • Meril Life Sciences Pvt. Ltd.

  • Organogenesis, Inc.

  • Sorin Group

  • St. Jude Medical, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/nlx1ul

View source version on businesswire.com: https://www.businesswire.com/news/home/20211018005699/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting